| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |